SCHEMBL753737

SCHEMBL753737

O=S(=O)(Cc1cccc(Cl)c1)C(I)I

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PNMT P11086 2/20 0.46
KMT2A Q03164 2/20 0.44
RXFP1 Q9HBX9 1/20 0.44
TAAR1 Q96RJ0 1/20 0.43
CTBP2 P56545 1/20 0.42
CYP3A4 P08684 2/20 0.42
IDO1 P14902 2/20 0.42
AGXT P21549 2/20 0.42
S100A9 P06702 1/20 0.42
GLA P06280 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
RIPK1 Q13546 1/20 0.40
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
MEN1 O00255 1/20 0.40
LMNA P02545 1/20 0.40
TAS2R14 Q9NYV8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL752569 0.82 PNMT (0.50) PNMTKMT2ARXFP1TAAR1CTBP2
SCHEMBL20682262 0.82 PNMT (0.53) PNMTKMT2ARXFP1TAAR1CTBP2
SCHEMBL294676 0.79 PNMT (0.54) PNMTKMT2ARXFP1TAAR1CTBP2
SCHEMBL8370549 0.79 PNMT (0.54) PNMTKMT2ARXFP1TAAR1CTBP2
SCHEMBL29581044 0.79 PNMT (0.54) PNMTKMT2ARXFP1TAAR1CTBP2
SCHEMBL749804 0.79 EGFR (0.43) TAAR1IDO1AGXTRIPK1MAOB
SCHEMBL30502958 0.77 PNMT (0.52) PNMTKMT2ARXFP1TAAR1CTBP2
SCHEMBL294675 0.77 PNMT (0.52) PNMTKMT2ARXFP1TAAR1CTBP2
SCHEMBL2343233 0.77 PNMT (0.52) PNMTKMT2ARXFP1TAAR1CTBP2
Hydrochloric Acid SCHEMBL28332854 0.77 PNMT (0.52) PNMTKMT2ARXFP1TAAR1CTBP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2213166-B1 Biocidal compounds containing 2-methylisothiazolin-3-one and a haloalkylsulfone THOR GMBH (DE) 2012-03-21 EP claimed
US-20100189811-A1 Biocide compositions comprising 3-methylisothiazolin-3-one and a haloalkyl sulphone THOR GMBH (DE) 2010-07-29 US claimed
US-8287631-B2 Compounds for preventing ghost odour THOR GMBH (DE) 2012-10-16 US disclosed
US-20100186631-A1 Compounds for preventing ghost odour THOR GMBH (DE) 2010-07-29 US disclosed
US-20100189811-A1 Biocide compositions comprising 3-methylisothiazolin-3-one and a haloalkyl sulphone THOR GMBH (DE) 2010-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100189811-A1 Biocide compositions comprising 3-methylisothiazolin-3-one and a haloalkyl sulphone MBTD1, MPST, B2M PNMT 3270/4885KMT2A 2043/4885RXFP1 4820/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.